Tilray Brands (TLRY) Change in Acquisitions & Divestments (2018 - 2020)
Tilray Brands (TLRY) posted Change in Acquisitions & Divestments of $6.2 million for Q2 2020, up 1313.27% on a QoQ basis from $437000.0 in Q1 2020, and up 157.58% year-over-year from $2.4 million in Q2 2019.
Tilray Brands (TLRY) Change in Acquisitions & Divestments (2018 - 2020) Analysis & Trends
Tilray Brands' Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at $6.2 million for Q2 2020.
- Quarterly Change in Acquisitions & Divestments rose 157.58% year-over-year to $6.2 million in Q2 2020, while the trailing twelve-month figure through May 2020 was -$4.1 million (down 122.03% YoY) and the FY2020 annual result came in at $4.1 million, down 99.71% from the prior year.
- Change in Acquisitions & Divestments was $6.2 million for Q2 2020 at Tilray Brands, up from $437000.0 in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $29.3 million in Q2 2018 and bottomed at -$10.7 million in Q2 2019.
- A 3-year average of $5.1 million and a median of $437000.0 in 2020 frame the typical range for Change in Acquisitions & Divestments.
- Peak annual rise in Change in Acquisitions & Divestments reached 157.58% in 2020, while the deepest fall reached 157.58% in 2020.
- Tilray Brands' Change in Acquisitions & Divestments stood at $29.3 million in 2018, then sank by 136.64% to -$10.7 million in 2019, then soared by 157.58% to $6.2 million in 2020.
- Business Quant data shows TLRY's Change in Acquisitions & Divestments at $6.2 million in Q2 2020, $437000.0 in Q1 2020, and -$10.7 million in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Tilray Brands | 452.95 Mn | 392.75 Mn | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2020 | 6.18 Mn |
| May 31, 2020 | 6.18 Mn |
| Mar 31, 2020 | 437,000.00 |
| Mar 31, 2020 | 437,000.00 |
| May 31, 2019 | -10.73 Mn |
| May 31, 2019 | -10.73 Mn |
| Jun 30, 2018 | 29.28 Mn |
| Jun 30, 2018 | 29.28 Mn |
| Mar 31, 2018 | 118,000.00 |
| Mar 31, 2018 | 118,000.00 |